CH
TRPX

CVI Holdings’s Therapix Biosciences Ltd. TRPX Stock Holding History

CVI Holdings’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,397
Closed -$98K – 90
2019
Q1 		$98K Buy
+31,397
New +$128K 0.09% 36

Other funds holding TRPX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

CVI Holdings's TRPX Position: Q2 2019 in Review

CVI Holdings sold out of Therapix Biosciences Ltd. (TRPX) in Q2 2019, closing a stake of 31,397 shares — an estimated $98K sold.

CVI Holdings first reported a position in TRPX in Q1 2019 and held it in 1 quarter. The position peaked at $98K in Q1 2019. 2 funds tracked by Wall St. Rank hold TRPX as of Q2 2019.

  • CVI Holdings reported no remaining Therapix Biosciences Ltd. position as of Q2 2019 after selling out during the quarter.
  • CVI Holdings sold 31,397 Therapix Biosciences Ltd. shares in Q2 2019, an estimated $98K.
  • CVI Holdings first reported a position in Therapix Biosciences Ltd. in Q1 2019 and held it in 1 quarter.
  • CVI Holdings's Therapix Biosciences Ltd. position peaked at $98K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q2 2019.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.